Insights

  • Date

  • Content Type

  • Reset

Article

Overcoming challenges for personalized cancer vaccines

11.04.22

By Ilona Baraniak and Aleksandra Nevmerzhitskaya

Advances in the field of personalized cancer vaccines create potential for more targeted, less toxic
Read More

Article

Opportunities for Growth and Breakthroughs for Cell and Gene Therapies

6.04.22

By Elena Meurer

A treatment that has been top-of-mind in recent years is cell and gene therapies (CGTs).
Read More

Video

Overcoming Key Regulatory Issues in Cell and Gene Therapies with Reliable and Expansive Expertise

1.04.22

By Emma Cheesman-Ungstrup


For this short interview Emma describes a few of her key takeaways from...

Read More

Blog

The Risk-Reward Conundrum

30.03.22

By Dr. Diane Seimetz

Opportunities and challenges of bringing innovative therapies to market.

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more